Jay Harper
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Angiogenesis and VEGF in Cancer 7
- Cancer therapeutics and mechanisms 4
- Chemical Synthesis and Analysis 3
- Oncology 13
- HER2/EGFR in Cancer Research 6
- Co-authors
- Marsha A. Moses (6 shared papers)Yan Li (1 shared paper)Catherine Butterfield (1 shared paper)Geraldine Jackson (1 shared paper)Yuen Shing (1 shared paper)Dmitri Wiederschain (1 shared paper)Jianmin Fang (1 shared paper)George S. Tamvakopoulos (1 shared paper)
- Journals
- Cancer Research (7 papers)Molecular Cancer Therapeutics (4 papers)Bioconjugate Chemistry (2 papers)Clinical Cancer Research (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Jay Harper
32 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 95
- Oncology 620
- Cancer Research 325
- Immunology and Allergy 105
- Radiology, Nuclear Medicine and Imaging 252
- Molecular Biology 635
Countries citing papers authored by Jay Harper
This map shows the geographic impact of Jay Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Harper more than expected).
Fields of papers citing papers by Jay Harper
This network shows the impact of papers produced by Jay Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Harper. The network helps show where Jay Harper may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay Harper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 326 | |
| 2 | 2015 | 106 | |
| 3 | 2017 | 98 | |
| 4 | 2009 | 97 | |
| 5 | 2009 | 94 | |
| 6 | 2018 | 88 | |
| 7 | 2006 | 78 | |
| 8 | 2012 | 77 | |
| 9 | 2001 | 64 | |
| 10 | 2011 | 57 | |
| 11 | 2007 | 45 | |
| 12 | 2015 | 34 | |
| 13 | 2013 | 30 | |
| 14 | 2019 | 28 | |
| 15 | 2019 | 22 | |
| 16 | 1986 | 20 | |
| 17 | 2019 | 19 | |
| 18 | 2019 | 17 | |
| 19 | 2017 | 17 | |
| 20 | 2018 | 14 |
About Jay Harper
Jay Harper is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 35 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Angiogenesis and VEGF in Cancer (7 papers), HER2/EGFR in Cancer Research (6 papers), Synthesis and pharmacology of benzodiazepine derivatives (6 papers), Click Chemistry and Applications (4 papers), Cancer therapeutics and mechanisms (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Oncology (620 citations), Cancer Research (325 citations), Immunology and Allergy (105 citations), Radiology, Nuclear Medicine and Imaging (252 citations) and Molecular Biology (635 citations). Jay Harper has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Marsha A. Moses, Yan Li, Catherine Butterfield, Geraldine Jackson, Yuen Shing, Dmitri Wiederschain, Jianmin Fang, George S. Tamvakopoulos, Shenlan Mao and Louis C. Gerstenfeld. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Bioconjugate Chemistry, Clinical Cancer Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.